Young breast cancer patients share views on fertility risks in new survey
NCT ID NCT00062400
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study surveyed 385 women aged 35 or younger with early-stage breast cancer to learn their attitudes about the risk of infertility from adjuvant therapy. The goal was to understand how concerns about having children might influence their treatment choices. The results could help doctors better support young patients in making informed decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this survey could help doctors better understand how young women weigh fertility risks when choosing breast cancer treatment, leading to more personalized care.
- What could go wrong
- This is a completed survey study, not a treatment trial. It gathered opinions but does not test any therapy or change outcomes directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Academisch Medisch Centrum at University of Amsterdam
Amsterdam, 1105 AZ, Netherlands
-
Algemeen Ziekenhuis Sint-Augustinus
Wilrijk, 2610, Belgium
-
American University of Beirut Medical Center
Beirut, 113-6044, Lebanon
-
Arnhems Radiotherapeutisch Instituut
Arnhem, 6815 AD, Netherlands
-
Azienda Istituti Ospitalieri
Cremona, 26100, Italy
-
CHU Liege - Domaine Universitaire du Sart Tilman
Liège, B-4000, Belgium
-
Centre Hospitalier Etterbeek Ixelles
Brussels, B-1050, Belgium
-
Centro di Riferimento Oncologico - Aviano
Aviano, 33081, Italy
-
Clinica Alemana
Santiago, 5951, Chile
-
European Institute of Oncology
Milan, 20141, Italy
-
Groote Schuur Hospital
Cape Town, 7925, South Africa
-
Hospital Militar
Santiago, Chile
-
Inselspital Bern
Bern, CH-3010, Switzerland
-
Institut Jules Bordet
Brussels, 1000, Belgium
-
Institute of Oncology and Radiology of Serbia
Belgrade, 11000, Serbia
-
Instituto Nacional de Enfermedades Neoplasicas
Lima, 34, Peru
-
Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA
Lisbon, 1099-023 Codex, Portugal
-
Instituto de Radiomedicina
Santiago, 10, Chile
-
Kantonsspital - St. Gallen
Sankt Gallen, CH-9007, Switzerland
-
Klinikum der J.W. Goethe Universitaet
Frankfurt, D-60590, Germany
-
Marmara University Hospital
Istanbul, 81190, Turkey (Türkiye)
-
Medical University of Gdansk
Gdansk, 80-211, Poland
-
Ospedale Alessandro Manzoni
Lecco, 23900, Italy
-
Ospedale Beata Vergine
Mendrisio, CH-6850, Switzerland
-
Universitatsklinikum Heidelberg
Heidelberg, 69115, Germany
-
University Hospital Rebro
Zagreb, 41000, Croatia
-
Western Infirmary
Glasgow, Scotland, G11 6NT, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?